enVVeno Medical Corp — Form SCHEDULE 13D/A
Filed September 15, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 22/100
What the filing says
Braeden Lichti filed an amended Schedule 13D/A regarding beneficial ownership in enVVeno Medical Corp (medical device manufacturer, ~$76.1M market cap). The filing is an amendment to a prior disclosure but specific ownership percentages, share counts, acquisition details, and dates of the amendment relative to the original filing are not disclosed in this header document. The substantive terms of the amendment cannot be determined from the metadata provided.
Why this rating
13D/A amendments are routine regulatory filings. Without disclosed ownership %, share count, or material transaction details in the header, cannot assess materiality. Requires review of full document.
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.